A coalition of university students yesterday joined forces with senior medical and legal figures in a campaign to press universities to ensure that drugs they help develop are made available at affordable prices in the developing world.

Senior public health advocates, practitioners and academic researchers helped launch the "Philadelphia consensus statement", calling for any university technology transfer licences to include conditions ensuring low-cost access to health-related innovations in the developing world.